デフォルト表紙
市場調査レポート
商品コード
1765150

末梢血管機器の世界市場

Peripheral Vascular Devices


出版日
ページ情報
英文 192 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.69円
末梢血管機器の世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

末梢血管機器の世界市場は2030年までに160億米ドルに達する見込み

2024年に127億米ドルと推定される末梢血管機器の世界市場は、分析期間2024-2030年にCAGR 4.0%で成長し、2030年には160億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである血管形成術ステントは、CAGR 4.6%を記録し、分析期間終了時には91億米ドルに達すると予測されます。血管形成術バルーンセグメントの成長率は、分析期間中CAGR 3.6%と推定されます。

米国市場は34億米ドル、中国はCAGR 3.6%で成長すると予測

米国の末梢血管機器市場は2024年に34億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに25億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは3.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.7%と3.3%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の末梢血管機器市場- 主要動向と促進要因のまとめ

末梢血管機器はなぜ現代医療に不可欠なのか?

末梢血管機器は、心臓や脳以外の動脈、静脈、リンパ管などの末梢血管に影響を及ぼす疾患の診断や治療に欠かせないツールです。ステント、カテーテル、バルーン、フィルターなどを含むこれらのデバイスは、末梢動脈疾患(PAD)、深部静脈血栓症(DVT)、慢性静脈不全(CVI)などの疾患を管理するために使用されます。これらの器具の重要性は、適切な血流を回復させ、合併症のリスクを減らし、患者の転帰を改善する能力にあります。例えば、血管形成術用のバルーンやステントは、狭窄したり閉塞した動脈を開いて血液循環を促進し、組織の損傷を防ぐために利用されます。これらの器具を用いた低侵襲手技の開発は血管手術に革命をもたらし、回復時間を短縮し、患者の生活の質を向上させました。

技術の進歩はどのように末梢血管機器を形成しているか?

技術の進歩は、末梢血管機器の機能性と有効性を大幅に向上させています。再狭窄を防ぐために薬剤を放出する薬剤溶出性ステントや、血流を回復させた後に徐々に溶解する生体吸収性ステントなどの革新的治療は、血管治療における重要なブレークスルーです。さらに、血管内超音波(IVUS)や光干渉断層計(OCT)などの画像診断技術の進歩により、ステント留置の精度や血管状態の評価が向上しています。形状記憶合金や生体適合性ポリマーのような先端材料の統合は、これらのデバイスの耐久性と性能を向上させています。さらに、ドラッグデリバリーや機械的支持など、複数の機能を組み合わせたハイブリッドデバイスの開発により、臨床医が利用できる治療の選択肢が広がっています。このような技術的進歩により、治療がより安全で、より効果的で、より侵襲の少ないものとなっています。

末梢血管機器の主な用途は?

末梢血管機器は、様々な医療分野に幅広く応用されています。インターベンショナル・カーディオロジーでは、これらの器具はPADの治療に使用されます。PADは、末梢動脈、一般的には脚の動脈の狭窄を特徴とし、痛みや移動の問題につながります。バルーンやステントを用いた血管内治療は、これらの動脈を再開通させ、血流を回復させて症状を緩和するのに役立ちます。血管外科では、グラフトや血管内動脈瘤修復(EVAR)システムなどの器具が動脈瘤の治療に欠かせないです。動脈瘤は血管壁の膨らみや弱くなった部分で、適切に管理されなければ破裂する可能性があります。さらに、末梢血管機器は、DVTのような静脈疾患の管理に不可欠であり、血栓除去装置やフィルターが肺塞栓症のような生命を脅かす合併症を予防します。様々な血管疾患に対応するこれらの機器の多用途性と有効性は、現代の医療現場におけるその重要性を際立たせています。

末梢血管機器市場の成長を促進する要因は?

末梢血管機器市場の成長は、いくつかの要因によって牽引されています。重要な促進要因の1つは、心血管疾患や、末梢血管障害のリスクを高める糖尿病や高血圧などのライフスタイル関連疾患の有病率の増加です。また、血管デバイスの安全性と有効性を高める技術の進歩も、治療可能な病態の範囲を広げ、患者の転帰を改善することから、市場の成長を後押ししています。さらに、高齢者は血管疾患にかかりやすいため、世界人口の高齢化が市場拡大に寄与しています。従来の手術に比べて回復時間が短く、合併症も少ない低侵襲手術に対する需要の高まりが、これらの機器の採用をさらに後押ししています。さらに、新興市場におけるヘルスケア支出の増加と先進医療技術へのアクセスの向上が、新たな成長機会を生み出しています。これらの要因が相まって、末梢血管機器市場は、革新的で効果的な血管治療への継続的なニーズが原動力となり、堅調な成長軌道を描いています。

セグメント

デバイスタイプ(血管形成術用ステント、血管形成術用バルーン、EVARステントグラフト、カテーテル、プラーク修正デバイス、血行動態変更デバイス、下大静脈フィルター、その他のデバイスタイプ)

調査対象企業の例

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular S.L.U
  • Medtronic PLC
  • Terumo Corporation

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13924

Global Peripheral Vascular Devices Market to Reach US$16.0 Billion by 2030

The global market for Peripheral Vascular Devices estimated at US$12.7 Billion in the year 2024, is expected to reach US$16.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Angioplasty Stents, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$9.1 Billion by the end of the analysis period. Growth in the Angioplasty Balloon segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 3.6% CAGR

The Peripheral Vascular Devices market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Peripheral Vascular Devices Market - Key Trends and Drivers Summarized

Why Are Peripheral Vascular Devices Essential in Modern Medicine?

Peripheral vascular devices are critical tools in the diagnosis and treatment of diseases affecting the peripheral blood vessels, including arteries, veins, and lymphatic vessels outside of the heart and brain. These devices, which include stents, catheters, balloons, and filters, are used to manage conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), and chronic venous insufficiency (CVI). The importance of these devices lies in their ability to restore proper blood flow, reduce the risk of complications, and improve patient outcomes. For instance, angioplasty balloons and stents are utilized to open narrowed or blocked arteries, enhancing blood circulation and preventing tissue damage. The development of minimally invasive techniques involving these devices has revolutionized vascular surgery, reducing recovery times and improving the quality of life for patients.

How Are Technological Advancements Shaping Peripheral Vascular Devices?

Technological advancements are significantly enhancing the functionality and efficacy of peripheral vascular devices. Innovations such as drug-eluting stents, which release medication to prevent restenosis, and bioresorbable stents, which gradually dissolve after restoring blood flow, represent significant breakthroughs in vascular treatment. Additionally, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are improving the precision of device placement and the assessment of vascular conditions. The integration of advanced materials, like shape-memory alloys and biocompatible polymers, is enhancing the durability and performance of these devices. Furthermore, the development of hybrid devices that combine multiple functions, such as drug delivery and mechanical support, is expanding the therapeutic options available to clinicians. These technological strides are making treatments safer, more effective, and less invasive.

What Are the Key Applications of Peripheral Vascular Devices?

Peripheral vascular devices have a wide range of applications across various medical disciplines. In interventional cardiology, these devices are used to treat PAD, which is characterized by the narrowing of peripheral arteries, typically in the legs, leading to pain and mobility issues. Endovascular treatments using balloons and stents help to reopen these arteries, restoring blood flow and alleviating symptoms. In vascular surgery, devices like grafts and endovascular aneurysm repair (EVAR) systems are essential for treating aneurysms, which are bulging or weakened areas in the vessel walls that can rupture if not managed properly. Additionally, peripheral vascular devices are crucial in managing venous diseases, such as DVT, where clot removal devices and filters prevent life-threatening complications like pulmonary embolism. The versatility and effectiveness of these devices in addressing various vascular conditions highlight their importance in contemporary medical practice.

What Factors Are Driving the Growth in the Peripheral Vascular Devices Market?

The growth in the peripheral vascular devices market is driven by several factors. One significant driver is the increasing prevalence of cardiovascular diseases and lifestyle-related conditions such as diabetes and hypertension, which heighten the risk of peripheral vascular disorders. Technological advancements that enhance the safety and efficacy of vascular devices are also propelling market growth, as they expand the range of treatable conditions and improve patient outcomes. Additionally, the aging global population is contributing to market expansion, as older adults are more susceptible to vascular diseases. The rising demand for minimally invasive procedures, which offer shorter recovery times and fewer complications compared to traditional surgeries, is further boosting the adoption of these devices. Moreover, increasing healthcare expenditure and improved access to advanced medical technologies in emerging markets are creating new opportunities for growth. These factors collectively ensure a robust growth trajectory for the peripheral vascular devices market, driven by the ongoing need for innovative and effective vascular treatments.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Other Device Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular S.L.U
  • Medtronic PLC
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Vascular Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Peripheral Artery Disease (PAD) Propels Growth in Peripheral Vascular Devices Market
    • Advances in Minimally Invasive Techniques Strengthen Business Case for Peripheral Vascular Devices
    • Increasing Adoption of Drug-Eluting Stents and Balloons Drives Market Growth
    • Expansion of Endovascular Procedures Generates Market Opportunities
    • Technological Innovations in Imaging and Navigation Systems Enhance Market Potential
    • Growing Geriatric Population Sustains Demand for Peripheral Vascular Interventions
    • Increasing Focus on Patient Safety and Outcomes Spurs Market Adoption
    • Development of Biodegradable and Bioabsorbable Devices Expands Addressable Market
    • Growing Awareness of Peripheral Vascular Diseases Spurs Market Demand
    • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
    • Increasing Investments in Healthcare Infrastructure Drive Adoption of Peripheral Vascular Devices
    • Expansion of Peripheral Vascular Device Applications in Emerging Markets Propels Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Vascular Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Vascular Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Peripheral Vascular Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Angioplasty Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Angioplasty Balloon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Angioplasty Balloon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Angioplasty Balloon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EVAR Stent Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EVAR Stent Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for EVAR Stent Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Inferior Vena Cava Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Inferior Vena Cava Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • CHINA
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Peripheral Vascular Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Peripheral Vascular Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 47: France Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: France Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: France 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Germany 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 53: Italy Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Italy Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Italy 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: UK 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of Europe 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Vascular Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of World Historic Review for Peripheral Vascular Devices by Device Type - Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of World 15-Year Perspective for Peripheral Vascular Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Stents, Angioplasty Balloon, EVAR Stent Grafts, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters and Other Device Types for the Years 2015, 2025 & 2030

IV. COMPETITION